0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial |  July 01, 2012
Vitamin D3 Supplementation to Preserve Pancreatic β-Cell Function in Newly Diagnosed Type 1 Diabetic Patients
Sheela N. Magge, MD, MSCE
Arch Pediatr Adolesc Med. 2012;166(7):664-666. doi:10.1001/archpediatrics.2012.500.
Article |  July 01, 2012
Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus
Mônica A. L. Gabbay, MD, PhD; Maria N. Sato, MD, PhD; Claudia Finazzo, MS(Biomed); et al.
Arch Pediatr Adolesc Med. 2012;166(7):601-607. doi:10.1001/archpediatrics.2012.164.
Article |  July 01, 2011 FREE
Prediction of Adolescents' Glycemic Control 1 Year After Diabetes-Specific Family Conflict:  The Mediating Role of Blood Glucose Monitoring Adherence
Marisa E. Hilliard, PhD; Shanna M. Guilfoyle, PhD; Lawrence M. Dolan, MD; et al.
Arch Pediatr Adolesc Med. 2011;165(7):624-629. doi:10.1001/archpediatrics.2011.86.
Article |  November 01, 2010 FREE
A Randomized Controlled Trial of Culturally Tailored Dance and Reducing Screen Time to Prevent Weight Gain in Low-Income African American Girls:  Stanford GEMS
Thomas N. Robinson, MD, MPH; Donna M. Matheson, PhD; Helena C. Kraemer, PhD; et al.
Arch Pediatr Adolesc Med. 2010;164(11):995. doi:10.1001/archpediatrics.2010.197.
The Pediatric Forum |  July 01, 2010
Analysis of Metformin Treatment for Adolescent Obesity at 48 Rather Than 24 Weeks After Treatment Cessation
Sana R. Sukkari, BSc Pharm, MPhil, PharmD; Larry D. Sasich, PharmD, MPH; Abdullah S. Humaidan, PharmD, FCCN, MPH; et al.
Arch Pediatr Adolesc Med. 2010;164(7):678-679. doi:10.1001/archpediatrics.2010.110.
The Pediatric Forum |  July 01, 2010
Analysis of Metformin Treatment for Adolescent Obesity at 48 Rather Than 24 Weeks After Treatment Cessation—Reply
Darrell M. Wilson, MD
Arch Pediatr Adolesc Med. 2010;164(7):678-679. doi:10.1001/archpediatrics.2010.111.
Article |  February 01, 2010 FREE
Metformin Extended Release Treatment of Adolescent Obesity:  A 48-Week Randomized, Double-Blind, Placebo-Controlled Trial With 48-Week Follow-up
Glaser Pediatric Research Network Obesity Study Group
Arch Pediatr Adolesc Med. 2010;164(2):116-123. doi:10.1001/archpediatrics.2009.264.
Article |  January 01, 2010 FREE
Childhood Predictors of Adult Type 2 Diabetes at 9- and 26-Year Follow-ups
John A. Morrison, PhD; Charles J. Glueck, MD; Paul S. Horn, PhD; et al.
Arch Pediatr Adolesc Med. 2010;164(1):53-60. doi:10.1001/archpediatrics.2009.228.
Article |  April 06, 2009 FREE
Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents
Joshua N. Liberman, PhD; Jan E. Berger, MD; Meredith Lewis, BS
Arch Pediatr Adolesc Med. 2009;163(4):357-364. doi:10.1001/archpediatrics.2009.5.
Article |  April 06, 2009 FREE
Reduction in Risk Factors for Type 2 Diabetes Mellitus in Response to a Low-Sugar, High-Fiber Dietary Intervention in Overweight Latino Adolescents
Emily Ventura, MPH; Jaimie Davis, PhD, RD; Courtney Byrd-Williams; et al.
Arch Pediatr Adolesc Med. 2009;163(4):320-327. doi:10.1001/archpediatrics.2009.11.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA
Health Agencies Update  |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
JAMA Internal Medicine
Editorial  |  April 22, 2013
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Internal Medicine
Original Investigation  |  February 25, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems